Published in
Elsevier, International Journal of Antimicrobial Agents, 4(62), p. 106952, 2023
DOI: 10.1016/j.ijantimicag.2023.106952
Links
Tools
Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe. A matched-paired analysis from the EPICOVIDEHA registry
Journal article published in 2023 by
Jon Salmanton-García 
,
Francesco Marchesi ,
Philipp Koehler,
Barbora Weinbergerová ,
Natasa Čolović,
Iker Falces-Romero ,
Caterina Buquicchio,
Francesca Farina,
Jens van Praet ,
Monika M. Biernat,
Federico Itri,
Lucia Prezioso,
Carlo Tascini,
Antonio Vena ,
Alessandra Romano
and other authors.
,
Francesco Marchesi ,
Philipp Koehler,
Barbora Weinbergerová ,
Natasa Čolović,
Iker Falces-Romero ,
Caterina Buquicchio,
Francesca Farina,
Jens van Praet ,
Monika M. Biernat,
Federico Itri,
Lucia Prezioso,
Carlo Tascini,
Antonio Vena ,
Alessandra Romano
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 